Second-trimester maternal serum marker screening: Maternal serum α-fetoprotein, β-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome
- 31 October 1999
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 181 (4), 968-974
- https://doi.org/10.1016/s0002-9378(99)70334-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcomeAmerican Journal of Obstetrics and Gynecology, 1994
- Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertensionAmerican Journal of Obstetrics and Gynecology, 1993
- Unexplained Elevations of Maternal Serum Alpha-FetoproteinObstetrical & Gynecological Survey, 1990
- Placental pathology at term associated with elevated midtrimester maternal serum α-fetoprotein concentrationAmerican Journal of Obstetrics and Gynecology, 1988
- Elevated maternal serum α-fetoprotein levels and oligohydramnios: Poor prognosis for pregnancy outcomeAmerican Journal of Obstetrics and Gynecology, 1987
- Beta‐human chorionic gonadotrophin levels before and after the development of pre‐eclampsiaBJOG: An International Journal of Obstetrics and Gynaecology, 1984
- MATERNAL SERUM ALPHA-FETOPROTEIN MEASUREMENT: A SCREENING TEST FOR DOWN SYNDROMEThe Lancet, 1984
- Fetal growth achievement and elevated maternal serum α‐fetoproteinBJOG: An International Journal of Obstetrics and Gynaecology, 1983
- MATERNAL SERUM-ALPHA-FETOPROTEIN MEASUREMENTS AS AN EARLY INDICATOR OF LOW BIRTH-WEIGHTThe Lancet, 1977
- Prenatal Diagnosis of Neural Tube DefectsPublished by American Medical Association (AMA) ,1976